Shingles

The investigators identified patients with a first-ever diagnosis of zoster who also had a child in the household with a varicella record.

Rates of some vaccinations are low in these patients, but pharmacists can play a key role in adherence.

Immunization needs for patients aged 19 to 64 years and afflicted with chronic conditions are often overlooked, and necessitate more attention and resources. Pharmacies traditionally do not focus on this patient population; instead often choosing to focus primarily on the population 65 years and over. However, engaging with patients in the 19- to 64-year-old group could go a long way in helping to fill the current immunization void in this population.

The study evaluated the safety and efficacy of a live, attenuated zoster vaccine patients receiving tumor necrosis factor inhibitor therapies for various indications.

Community pharmacies that provide immunization services have proven their success time and again, but they still face roadblocks. Many state laws and regulations still do not allow pharmacies to take full responsibility for vaccinations, and states regulate immunization services at pharmacies in different ways.

Life-saving vaccines have had a profound impact in this country and worldwide. According to the CDC, from 2006 to 2017, almost 3.5 billion doses of vaccines were distributed in the United States.

The goal of the Healthy People initiative is to “provide science-based, 10-year national objectives for improving the health of all Americans.”

The community pharmacist wears multiple hats in the daily delivery of health care to patients, one of which might be providing immunization services. Certainly, the patient who walks in for an immunization benefits from the convenience provided by the community pharmacy.

They have become more important in health care delivery yet represent a smaller portion of the bill.

The most common chronic conditions, and the biggest drivers in annual health care costs for US adults, include heart disease, cancer, chronic lung disease, diabetes, and chronic kidney disease.

Herpes zoster, also known as zoster or shingles, is caused by the reactivation of the varicella zoster virus. After an individual has been exposed to the varicella virus through chickenpox or via vaccination, the virus remains dormant in the dorsal root ganglia.

Herpes zoster, commonly known as shingles, is characterized by a painful, itchy rash and blisters, often resulting in permanent neuropathic pain (postherpetic neuralgia) that can be difficult to manage.

Pharmacists are now core members of the vaccination community, playing a role in vaccine accessibility, opportunity, identification, and safety.

Prior to vaccines, immunity to a disease was acquired solely through contracting the illness.

Singrix is a recombinant vaccine indicated for the prevention of herpes zoster in older adults.

Herpes zoster, also known as shingles, is a painful rash caused by a reactivation of the varicella-zoster virus, also called the chickenpox virus.

Ingenol mebutate (Picato) gel's label must now include reported risks of shingles and anaphylaxis.

Vigilant pharmacists can help patients identify postinfection complications.

The impact of varicella-zoster virus vaccination programs on the US population is not yet clear.